A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

Gadar 3 EXCLUSIVE: Sunny Deol says he ‘would love to play Tara Singh over and over again’; shares the reason behind it Did King helmer Siddharth Anand hint at reports of Deepika Padukone’s ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Penny Gusner is a senior insurance writer and analyst at Forbes Advisor. For more than 20 years, she has been helping consumers learn how insurance laws, data, trends, and coverages affect them.

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

The A1C test measures a person’s average blood glucose or blood sugar levels over the past 3 months. An A1C reading of over 5.6% may be a cause for concern, but this will depend on various ...

Q3 at SAR 1.2BArgaam Special10/11/2024 A look at Saudi insurance sector’s P/E ratio in H1 2024Argaam Special15/08/2024 Saudi insurance sector's combined profit up 25% at SAR 2.23B in H1 2024; Q2 at ...

Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years of hands-on experience in both business and personal finance. She is passionate about ...

Q3 at SAR 1.2BArgaam Special10/11/2024 A look at Saudi insurance sector’s P/E ratio in H1 2024Argaam Special15/08/2024 Saudi insurance sector's combined profit up 25% at SAR 2.23B in H1 2024; Q2 at ...

As Congress gears up to pass President Trump’s massive legislative package, one of the biggest fights is over the future of Medicaid. To make their targeted budget numbers, Republicans will ...

Most of the insurance changes are targeted at drugs used for weight loss. Ozempic, an especially well-known drug of this class, is approved by the FDA to treat diabetes and prevent heart failure ...